Work

Subgroup analysis of leiomyosarcoma (LMS) patients (pts) from a phase 3, open-label, randomized study of eribulin (ERI) versus dacarbazine (DTIC) in pts with advanced liposarcoma (LPS) and LMS

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw388.07

Authors: J.-Y. Blay, P. Schoffski, S. Bauer, A. Krarup-Hansen, C. Benson, D.R. D'Adamo, M. Guo, R. Maki

Institutions: Centre Léon Bérard, Universitair Ziekenhuis Leuven, University of Duisburg-Essen, University of Copenhagen, Herlev Hospital, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, Eisai (United States), Tisch Cancer Institute

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2588719221

FWCI: 0.298

Cites:

Cited by: 1

Related to: 10